Evidence map›Paper›PMID 27518770›Full record

ArticleJournal of inherited metabolic disease2016

mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.

Kara R Vogel, Garrett R Ainslie, K Michael Gibson

Open access · greenAbstract read
In one paragraph

Article in Journal of inherited metabolic disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
8.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kara R VogelDivision of Experimental and Systems Pharmacology, College of Pharmacy, Washington State University, Pharmaceutical and Basic Sciences Building Room 347, 412 E. Spokane Falls Blvd, Spokane, WA, 99202, USA. k.vogel@wsu.edu.
Garrett R AinslieDivision of Experimental and Systems Pharmacology, College of Pharmacy, Washington State University, Pharmaceutical and Basic Sciences Building Room 347, 412 E. Spokane Falls Blvd, Spokane, WA, 99202, USA.
K Michael GibsonDivision of Experimental and Systems Pharmacology, College of Pharmacy, Washington State University, Pharmaceutical and Basic Sciences Building Room 347, 412 E. Spokane Falls Blvd, Spokane, WA, 99202, USA.
Washington State University Spokane · US

Funding

Therapeutics of mTOR Signaling in Succinic Semialdehyde Dehydrogenase DeficiencyR21NS085369 · NINDS · WASHINGTON STATE UNIVERSITY · PI GIBSON, K MICHAEL · 2014 to 2015
$432k
NINDS NIH HHS R21 NS085369
6 · The paper itself

Abstract

Recent studies have identified a role for supraphysiological gamma-aminobutyric acid (GABA) in the regulation of mechanistic target of rapamycin (mTOR), a protein kinase with pleiotropic roles in cellular development and homeostasis, including integration of growth factors and nutrient sensing and synaptic input in neurons (Lakhani et al. 2014; Vogel et al. 2015). Aldehyde dehydrogenase 5a1-deficient (aldh5a1

Indexed as

Amino Acid Metabolism, Inborn ErrorsAnimalsDevelopmental DisabilitiesDisease Models, Animalgamma-Aminobutyric AcidGlutamic AcidMiceMorpholinesNeuronsPremature BirthPyrimidinesQuinoxalinesSirolimusSuccinate-Semialdehyde DehydrogenaseSulfonamidesSynaptic Transmissiongamma-Aminobutyric AcidGlutamic AcidKu 0063794MorpholinesPyrimidinesQuinoxalinesSirolimusSuccinate-Semialdehyde DehydrogenaseSulfonamidesTOR Serine-Threonine KinasesXL765

Identifiers

PMID27518770
PMCPMC5114712
OpenAlexW2508937532

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.